1. Cell Stem Cell. 2016 Oct 6;19(4):476-490. doi: 10.1016/j.stem.2016.08.008.
Epub  2016 Sep 8.

Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent 
Stem Cell State.

Gu W(1), Gaeta X(2), Sahakyan A(3), Chan AB(1), Hong CS(1), Kim R(4), Braas 
D(5), Plath K(6), Lowry WE(7), Christofk HR(8).

Author information:
(1)Department of Molecular and Medical Pharmacology, David Geffen School of 
Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
(2)Department of Molecular, Cell, and Developmental Biology, University of 
California, Los Angeles, Los Angeles, CA 90095, USA.
(3)Department of Biological Chemistry, David Geffen School of Medicine, 
University of California, Los Angeles, Los Angeles, CA 90095, USA; Molecular 
Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095, 
USA.
(4)Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, 
University of California, Los Angeles, Los Angeles, CA 90095, USA.
(5)Department of Molecular and Medical Pharmacology, David Geffen School of 
Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; 
UCLA Metabolomics Center, Los Angeles, CA 90095, USA.
(6)Department of Biological Chemistry, David Geffen School of Medicine, 
University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and 
Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University 
of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive 
Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, 
USA.
(7)Department of Molecular, Cell, and Developmental Biology, University of 
California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center 
of Regenerative Medicine and Stem Cell Research, University of California, Los 
Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, David 
Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. Electronic 
address: blowry@ucla.edu.
(8)Department of Molecular and Medical Pharmacology, David Geffen School of 
Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; 
Department of Biological Chemistry, David Geffen School of Medicine, University 
of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad 
Center of Regenerative Medicine and Stem Cell Research, University of 
California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive 
Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, 
USA; UCLA Metabolomics Center, Los Angeles, CA 90095, USA. Electronic address: 
hchristofk@mednet.ucla.edu.

Comment in
    Cell Stem Cell. 2016 Oct 6;19(4):419-420. doi: 10.1016/j.stem.2016.09.005.
    Stem Cell Investig. 2017 Feb 13;4:9. doi: 10.21037/sci.2017.01.03.

The rate of glycolytic metabolism changes during differentiation of human 
embryonic stem cells (hESCs) and reprogramming of somatic cells to pluripotency. 
However, the functional contribution of glycolytic metabolism to the pluripotent 
state is unclear. Here we show that naive hESCs exhibit increased glycolytic 
flux, MYC transcriptional activity, and nuclear N-MYC localization relative to 
primed hESCs. This status is consistent with the inner cell mass of human 
blastocysts, where MYC transcriptional activity is higher than in primed hESCs 
and nuclear N-MYC levels are elevated. Reduction of glycolysis decreases 
self-renewal of naive hESCs and feeder-free primed hESCs, but not primed hESCs 
grown in feeder-supported conditions. Reduction of glycolysis in feeder-free 
primed hESCs also enhances neural specification. These findings reveal 
associations between glycolytic metabolism and human naive pluripotency and 
differences in the metabolism of feeder-/feeder-free cultured hESCs. They may 
also suggest methods for regulating self-renewal and initial cell fate 
specification of hESCs.

Copyright © 2016 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.stem.2016.08.008
PMCID: PMC5055460
PMID: 27618217 [Indexed for MEDLINE]